Dow Jones Top Company Headlines at 3 AM ET: Sanofi Multiple Sclerosis Drug Hit by Double Setback | China ... A U.S. regulatory decision on tolebrutinib will again be delayed while a late-stage trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback